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Objectives: The efﬁcacy and safety of endovascular aneurysm repair is disputable in aneurysms with
a short, angulated, wide, conical, or thrombus-lined neck making a reliable seal difﬁcult to achieve. The
inﬂuence of a challenging neck on early results using the Endurant stent-graft system in high risk
patients was investigated.
Materials and methods: A retrospective study conducted on a prospectively compiled database of 72
elective patients with challenging neck treated with the Endurant system (Endurant Stent Graft, Med-
tronic AVE, Santa Rosa, CA, USA). These patients were compared to a control group (n ¼ 65) without
signiﬁcant neck problems. Endpoints were early technical and clinical success, deployment accuracy and
differences in operative details at one month follow-up. Data are reported as mean and standard devi-
ation or as absolute frequency and percentage (%). Normality distribution and homogeneity of variances
were tested by ShapiroeWilks and Levene tests, respectively. Inter-group comparisons for each variable
were made by t-test or c2-test or Fisher exact test. A p < 0.05 was considered statistically signiﬁcant.
Results: Mean age was 76.12 years; 76.6% were males. Risk factors and pre-operative variables did not
differ signiﬁcantly between the two groups. Mean neck length was 10.56 mm in patients with chal-
lenging anatomies and 22.85 mm in controls. Patients with a challenging neck differed signiﬁcantly
(p < 0.001) from controls in terms of mean infrarenal (37.67 vs. 20.12) and suprarenal angle (19.63 vs.
15.57); 82% of patients with a challenging neck were ASA III/IV (vs. 86%). Technical success was 100%,
with four unplanned proximal extension in challenging group. No type I endoleaks or aneurysm-related
deaths occurred in either group; major complications were 1.54% vs. 1.39% (p ¼ 0.942). Operative details
were similar in both groups.
Conclusion: Treatment with the Endurant stent-graft is technically feasible and safe, yielding satisfactory
results even in challenging anatomies. Medium- and long-term data are needed to verify durability, but
early results are promising.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction management of challenging necks also presents difﬁculties relatedEndovascular aneurysm repair (EVAR) is considered a safe and
effective alternative to open repair (OR) for the treatment of
selected cases of abdominal aortic aneurysm (AAA).1e4 However,
the efﬁcacy and safety of EVAR for aneurysms with challenging
anatomies remains disputable, due to the technical difﬁculties of
achieving a reliable seal with a stent-graft. The more frequent
complications after EVAR in aneurysms with a complex proximal
neck anatomy require intraoperative endovascular adjuncts, with
a higher risk of late aneurysm rupture due to proximal type I
endoleaks, even in the absence of graft migration.5,6 Surgical: þ39 0577 233426.
ciety for Vascular Surgery. Publishto the possibility of extending the dissection over the renal arteries,
with related complications. Nowadays difﬁcult anatomies can also
be treated with fenestrated or branched stent-grafts. However,
while the results reported in the literature seem promising, these
procedures are very expensive.7 The use of a standard endopros-
thesis (when possible) is still the most reliable and cost-effective
procedure. It is, therefore, unclear whether EVAR or OR should be
offered in the case of aneurysms with a challenging proximal aortic
neck.8 Over the years, many technological advances have been
introduced, bringing progressive improvements and allowing
aneurysms with challenging necks to be operated on safely. The
Endurant endograft (Medtronic AVE, Santa Rosa, CA, USA) is a new-
generation device for AAA repair that has been speciﬁcally
designed to conform to challenging anatomy. With its easy-to-ed by Elsevier Ltd. All rights reserved.
Table 1
Demographic and preoperative risk factors of the control group and challenging
neck group.
Control group Challenging group p value
n 65 72
Age (years) 75.12 (6.35) 77.24 (5.98) 0.05
Gender (male/female) 48/17 57/15 0.546
Smoking 40 (61.54%) 51 (70.83) 0.28
Hypertension 44 (67.69%) 46 (63.89%) 0.72
CADx 37 (56.92%) 36 (50.00%) 0.493
COPD* 22 (33.85%) 19 (26.39%) 0.357
Diabetes 17 (26.15%) 18 (25.00%) 0.877
Renal Disease 10 (15.39%) 15 (20.83%) 0.41
PAOD$ 17 (26.15%) 13 (18.06%) 0.252
CVD& 8 (12.31%) 7 (9.72%) 0.628
ASA III/IV# 56 (86.15%) 59 (81.94%) 0.503
x Coronary Artery Disease; * Chronic obstructive pulmonary disease; $ Peripheral
Artery Obstructive Disease; & cerebrovascular disease; # American Society of
Anestesiologist.
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suited to treating AAA patients with challenging anatomy. Our
study investigated the inﬂuence of a challenging neck on early
results using the Endurant stent-graft system, compared to a group
of patients without signiﬁcant neck problems. The aim of our study
was to demonstrate the effectiveness of the latest generation of
endoprostheses in patients with difﬁcult anatomy.
Materials and Methods
Study design and patient selection
A single centre study was conducted on a prospectively compiled
computerized database between January 2010 and December 2010,
with the aim of demonstrating the early safety and efﬁcacy of EVAR in
challenging aortic neck morphologies using the Endurant stent-graft
system. In the present study out of 236 patients who received treat-
ment, 137 non-consecutive patients were analyzed and divided into
twogroups (challenging anatomies vs. controls). The selection of study
populationwasperformed includingonlypatients treatedbyEndurant
stent-graft system. The remaining patientswere treatedwith different
stent graft and were excluded from the analysis in order to avoid
a potential confounding factor. EVAR indications were based on age
(>80 years), left ventricular ejection fraction (<25%), hostile abdomen,
renal function impairment (serum creatinine> 2.0 mg/dL), or chronic
pulmonary disease (forced expiratory volume in 1 s <1 L). AAA
morphology was assessed by preoperative contrast-enhanced
computed tomography (CT). The aneurysm neck was classiﬁed as
“challenging” in the presence of one or more of the following
criteria9e12: (1) hourglass neck, (2) angulated neck: 60 angle
between the juxtarenal aorta and long axis of the aneurysm sac, (3)
shortneck:neck length<15mm, (4) signiﬁcant thrombus:>50%of the
proximal neck circumference covered, (5) reverse conical neck: neck
dilated  2 mmwithin 10 mm of the most caudal renal artery, or (6)
barrel neck: focal neck enlargement 3mmwithin15mmof themost
caudal renal artery. All other morphologies were classiﬁed as “non-
challenging”. Even in the presence of “challenging neck anatomy” we
decide to include patients with a proximal neck length of more than
20mmandwithout signiﬁcant aortic angulations in the control group.
Database interrogation identiﬁed 72 elective high-risk patients
with AAA and challenging neck anatomy treated with the Endurant
stent-graft system. These patientswere compared to a control group
(n ¼ 65) without signiﬁcant neck problems who had undergone
EVAR using the same device during the same period (Table 1).
Preoperative planning
CTangiographywasperformedusing a 64-slice LightSpeedCT (GE
Healthcare, Salt Lake City, UT, USA) with and without contrast
mediumduringarterial andvenousphases, at a thickness of 1mm.All
measurements (diameter, length and volume) were performed using
a workstation with dedicated reconstruction software and centre
lumen line (CLL) reconstruction (OsiriX software version 3.2.1 on
a regular Mac OS X computer and 3Mensio Medical Imaging B.V.,
Bilthoven, The Netherlands). Post-analysis included 3D volume
rendering, preoperative simulated angiography and multiplanar
reconstruction (Fig. 1). Brieﬂy, to measure aortic angulation, a CLL of
the aorta was made, and a three-dimensional (3D) aortic recon-
struction was obtained. The 3D reconstruction was turned 360
perpendicular to the CLL in the middle of the ﬂexure. The sharpest
angle was considered the true angle of the aortic axis. The angles
between the suprarenal aorta and the aneurysm neck (a) and
between the aneurysmneck and sac (b) weremeasured (Fig. 2). After
CLL reconstruction, subsequent measurements were performed. The
length of the proximal neck was deﬁned as the distance between theorigin of the lowermost renal artery and beginning of the aneur-
ismatic dilatation. Volumes were acquired for both the neck (ﬁrst
10 mm) and total aneurysm (up to the bifurcation). Preoperative
planning was performed by the same operators and was always dis-
cussedwith aMedtronic Products specialist. Postoperative computed
tomography angiography (CTA)was performed on all patientswithin
30 days of surgery.
Surgical procedure
All patients were treated under local anesthesia in an operating
theater equipped with a portable ﬂuoroscopy unit (GE-OEC 9900;
GE Healthcare, Salt Lake City, UT, USA). Bilateral cut-down of the
common femoral artery was performed in 124 (90.5%) cases,
a monolateral percutaneous approach using the Perclose Prostar XL
device (Abbott Vascular, Redwood City, CA, USA) was chosen for 7
(5.1%) patients, and an all percutaneous approach was selected in
the other 6 (4.3%) cases. Based on the preoperative simulated
angiography, the C-arm was placed with the right orientation to
allow optimum visualization of the proximal aortic neck. We
usually perform the ﬁrst angiography at the level of the renal
arteries, which requires lower volume contrast injection, with the
stent-graft in place ready for release. In order to avoid uninten-
tional renal artery occlusion in the case of a proximal aortic neck
length of less than 10 mm, we always place two guidewires in the
renal artery, to facilitate performance of a chimney technique if
necessary. When the proximal neck is not completely covered we
prefer to place a proximal stent-graft extension after the ﬁnal
angiography, even without a type I endoleak.
Endpoints and deﬁnitions
The endpoints were early technical and clinical success. Primary
technical success, assessed on an intention-to-treat basis, was
deﬁned as successful implantation of a stent-graft in the absence of
surgical conversion, mortality, type I or III endoleaks, or stent-graft
occlusion in the ﬁrst 24 h after surgery. The need for postoperative
adjunctive endovascular procedures and postoperative reinter-
vention was noted. Clinical success was deﬁned as the absence of
any signiﬁcant intraoperative, 30-day or in-hospital mortality or
morbidity. Late rupture, major adverse event (MAE), minor adverse
event (minor AE), AAA-related mortality and all-cause mortality
were noted. We considered as a MAE acute myocardial infarction
(AMI), ileus, spinal cord ischemia (SCI), renal dysfunction (RD),
respiratory failure (RF) and blood loss requiring transfusion.
The post-operative permeability of renal arteries was assessed
in both groups.
Figure 1. (A) 3-D volume rendering CT reconstruction; (B) preoperative simulated angiography; (C) center-line analysis.
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conﬁrmed by the elevation of cardiac enzymes, regardless of symp-
toms. Ileuswasdeﬁned as a delay in gutmotility lasting formore than
72 h after surgery,while SCIwas deﬁned as postoperative evidence of
neurological deﬁcits. RD was deﬁned as a rise in serum creatinine
exceeding the baseline value by 30% and surpassing an absolute level
of 2.0 mg/dL. RF was deﬁned as ventilator dependence of>72 h, and
the need for postoperative reintubation. The differences in operative
details were also analyzed.Follow-up protocol
Routine follow-up was planned according to the standard
requirements suggested by the European Society for Vascular and
Endovascular Surgery’s recent clinical practice guidelines.7 All
patients had a CTA and plain radiographs with anteroposterior and
lateral projections 30 days after the procedure. In the case of any
endoleak, less than one stent component or iliac overlap, CTA with
plain radiographs were performed again at 6 and 12 months. In
patients with no early endoleak and good component overlap,
a CTA alone was performed at 12 months. When there was no
endoleak and a stable or shrinking AAA at 12 months, a yearlyFigure 2. (A) a angle: suprarenal angulation; (B) b angle: iuxtarenal angulation.duplex ultrasound scan was scheduled along with plain radio-
graphs, using a standardized protocol with anteroposterior and
lateral projections to assess device migration, stent fractures and/or
modular disconnections.
Statistical analysis
The data are reported as mean and standard deviations (SD) or
as absolute frequencies and percentages (%). Normality distribution
and the homogeneity of variances were assessed by the
ShapiroeWilk test and Levene’s test, respectively. Inter-group
comparisons for each variable were performed using the t-test,
c2-test or Fisher’s exact test. A p value < 0.05 was considered
statistically signiﬁcant. All analyses were calculated using SPSS
statistical software version 13 (SPSS Inc., Chicago, IL).
Results
Analysis of demographics and preoperative risk factors (Table 1)
showed that the two groupswere generally comparable: of notewas
only a p value of 0.05 for the age between the two groups, probably
due to the small number of patients analyzed. The mean age was
76.12 years; 76.6% were males. Eighty-two percent of patients with
a challenging neck were ASA III/IV, according to the classiﬁcation of
the American Society of Anaesthesiologists (vs. 86% in the control
group; p ¼ 0.503). Patients with challenging neck anatomies pre-
sentedhigher rates of renal dysfunction (20.83%vs.15.39%;p¼0.41).
Neck morphology
The mean maximum diameter was 65.35 mm in the challenging
groupversus 67.41mmin the control group (p¼ 0.067).Neckdiameter
was quite similar in both groups (24.19 mmvs. 24.35 mm; p ¼ 0.587).
The mean neck length was 10.56 mm in patients with challenging
anatomies and 22.85 mm in the control group (p < 0.001). Data
regarding neck calciﬁcation or thrombosis were statistically compa-
rable in both groups (p ¼ 0.597, p ¼ 0.935 respectively). Patients with
a challenging neck differed signiﬁcantly (p < 0.001) from controls in
termsofmean infrarenal angle (37.67 vs. 20.12) and suprarenal angle
(19.63 vs. 15.57). Neck morphology was classiﬁed as one of ﬁve
different neck shapes: cylindrical, conical, barrel, hourglass, reverse
conical. The group distribution is described in Table 2.
Thirteen patients with “challenging neck anatomy” (3 barrel, 3
hourglass and 7 reverse conical necks) were included in the control
Table 2
Group distribution according to aneurysm proximal neck features.
Control group Challenging group p value
Max. diameter 67.41 (6.56) 65.35 (6.55) 0.067
Neck diameter 24.35 (1.66) 24.19 (7.76) 0.587
Neck length 22.85 (5.40) 10.56 (1.99) <0.001
Thrombus >30% 16 (24.62%) 15 (20.83%) 0.597
Calciﬁcaton >30% 13 (20.00%) 14 (19.44%) 0.935
Alfa angle 15.57 (6.92) 19.63 (10.73) <0.001
Beta angle 20.12 (9.99) 37.67 (19.16) <0.001
Cylindrical neck 35 (53.85%) 45 (62.50%) 0.305
Conical neck 18 (27.69%) 15 (20.83%) 0.349
Barrel neck 3 (4.62%) 7 (9.72%) 0.332
Hourglass neck 3 (4.62%) 5 (6.94%) 0.721
Reverse conical neck 7 (10.80%) 2 (2.77%) 0.085
Table 3
Intra operative/30-days complications and operative details.
Control group Challenging group p value
Primary technical success 65 72 e
Adjunctive procedure 8 (12.31%) 8 (11.11%) 0.828
Intra OP EL 0 0 e
30d EL 0 0 e
Migration 0 0 e
Duration 83.69 (12.88) 84,17 (12,64) 0.828
Radiation Time 13.23 (7.72) 13,67 (1,89) 0.162
MAE 1 (1.54%) 1 (1.39%) 0.942
Minor AE 2 (3.08%) 3 (4.17%) 0.734
Reintervention 0 0 e
Rupture 0 0 e
AAA-related mortality 0 0 e
All cause mortality 1 (1.54%) 2 (2.77%) 0.621
Hospital stay (days) 3 28 (43.08%) 36 (50.00%) 0.917
4 27 (41.54%) 26 (36.11%)
5 5 (7.69%) 6 (8.33%)
6 2 (3.08%) 2 (2.77%)
7 3 (4.62%) 2 (2.77%)
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the absence of signiﬁcant aortic angulations. Technical success was
100%, with four unplanned proximal aortic cuff extensions in the
challenging group. We placed two safety guidewires in 19 (13.68%)
“challenging neck” patients with a neck length of less than 10 mm.
No type I endoleaks or aneurysm-related deaths occurred in either
group; major complications were 1.54% vs. 1.39% (p ¼ 0.942).
Operative details were similar in both groups. Neck morphology
was not related to MAE, minor AE, re-interventions, rupture or
AAA-related mortality.Procedure results
The mean operation times were 84.17 and 83.69 min in the
challenging group and control group, respectively (p ¼ 0.828).
Challenging neckmorphology did not signiﬁcantlymodify radiation
time (13.67vs.13.23min). Primary technical successwas achieved in
all cases. Although one of the problems reported with Endurant
stent-grafts in short and tightly angulated necks is the difﬁculty of
retrieving the conical proximal shelter for thenon-coveredproximal
stent: fortunatelywedidnotexperience this situation.Notype I or III
endoleaks requiring adjunctive endovascular procedures were
detected in our series. All the renal arteries were patent at
completion angiography and at the 1 month angio-CT. One case of
RD was recorded in both groups, characterized by reversible post-
operative elevation of serum creatinine levels bymore than 2.0 mg/
dL, requiring volume supplementation with sodium bicarbonate
plus N-acetylcysteine, according to the REMEDIAL trial protocol.13
There were 3 minor AE in the challenging neck group (1 surgical
wound infection, 2 transient fever) and 2 cases of transient amnesia
in the control group. The majority of patients were discharged on
postoperative day 3 or 4 (themeanhospital staywas 3.72 days in the
challenging group and 3.84 in the control group; p:ns). No patients
required an ICU stay. We reported 3 non-AAA related deaths: two
patients (one in the study group and one in the control group) died
from AMI after hospital discharge, and 1 patient in the challenging
anatomies group had a sudden death (no autopsy report). (Table 3)Discussion
An unsuitable proximal neck is one of the main factors limiting
the wider applicability of EVAR.14e16 Until approximately ten years
ago, unfavourable anatomy of the proximal aortic neck was
responsible for about 60% of patient exclusion from EVAR.17 Today’s
advanced technology has increased the number of patients suitable
for EVAR, but the choice between OR or EVAR in patients with
challenging aortic neck anatomy still remains controversial. Chal-
lenging aortic morphology requires adequate preoperative plan-
ning in order to minimize procedure-related complications.In the present series, we compared patients with normal and
challenging neck anatomy undergoing EVAR for AAA using the
Endurant stent-graft. This newgeneration device obtained the Con-
formité Européenemark in July 2008 and is commercially available in
all European countries. Themain features of this endograft have been
described in other reports.18e20 The device has greater ﬂexibility due
to shorter and wire-formed M-shaped body stents. This increased
ﬂexibility allows the stent-graft to be successfully used in aneurysms
with severely angulated and tortuous anatomies. The suprarenal
anchoringpinsand thecontrolled releaseof the topstentensureexact
proximal ﬁxation to the aortic wall and reduce the risk of migration.
Recent series have sought to analyze the short-term results of this
new stent-graft, particularly in patients with complex aortic
morphologies. The ﬁnal results of the prospective European multi-
centre non-randomized trial of the Endurant stent-graft for EVAR
showed that this stent-graft was successfully delivered and deployed
in all cases, with safe and effective performance in all patients,
including those with unfavourable (angulated) proximal neck
anatomy.21 Similar results have been published by Bastros Gonçalves
et al., who considered treatment with the Endurant stent-graft
feasible and safe, achieving satisfactory results in angulated and
non-angulated anatomies alike.22Off-label indications suchasa short
(15 mm) proximal aortic neck associated with severe infrarenal
neck angulation (75) are responsible for procedure-related
complications with a greater risk of type I endoleak, although
mortality and morbidity remain comparable to those in/the same as
inpatientswithout aorticneckproblems.23,24Ourdatadonot support
the conclusions of a previous study regarding postoperative
morphology-related complications. The present study suggests that
the results of EVAR are similar in challenging neck anatomies and in
patients without signiﬁcant neck problems. The manufacturer’s
device-speciﬁc instructions for use recommend a proximal aortic
neck of 15 mm in length with 75 infrarenal angulation or
a proximal aortic neck of 10 mm with 60 infrarenal angulation.
We decided to use the stent for “off-label” applications only in
patients with serious comorbidities who were unsuitable for OR.
None of these patients presented postoperative or 30-day type I
endoleak.Onepatientoutof three (33%)with theassociationbetween
a proximal aortic neck of 15 mm (but >10 mm) in length and with
60infrarenal angulation required an adjunctive procedure of
proximal stent-graft extension due to the presence of an additional
space between the graft and the lower renal artery. Three patients out
of 25 (12%)with a proximal aortic neck length of10mmrequired an
adjunctiveprocedure for the samereason.Onlyonepatientpresented
the second manufacture contraindication but fortunately did not
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for EVAR in challenging cases plays a leading role in avoiding intra-
operative complications.25e27 Longer and stiffer stents make the
accommodation of angulated proximal implantation zones more
challenging and may contribute to proximal attachment site endo-
leaks or graft kinking when deployment occurs in tortuous vessels.28
The deployment of ﬂexible and conformable stent-grafts with prox-
imal anchoring pins appears to be safer in patients with challenging
anatomies.9,24,29 The next generation of stent-graft designs currently
evolving are addressing the issues that affect the further expansion of
EVAR applicability: the Aorﬁx (Lombard Medical Technologies plc.,
Didcot, UK) and the Anaconda device (Vascutek Ltd., Terumo, Ren-
frewshire, Scotland) have been studied, but usually result in a higher
rate of type I endoleak.28,30
The use of a mobile c-arm in challenging aortic morphologies is
not widely recognised and could be a limiting factor. However, our
institution does not have a hybrid operating room: the need to
perform these procedures in the operating room therefore implies
that we have to use a mobile c-arm.
The retrospective nature of this study may result in signiﬁcant
bias. However, all patients selected for EVAR were treated in
a consecutive fashion with the same stent-graft. Patients in the
challenging neck group were individually scheduled for OR, EVAR
or no treatment primarily according to their comorbidities, thus
skewing this group towards a generally lower health status. This
did not result in any difference in the short-term, but may do so in
the future. Lastly, the relatively small numbers presented may be
insufﬁcient to reveal differences between groups.
Conclusions
In our centre treatment with the Endurant stent-graft is tech-
nically feasible and safe, yielding satisfactory results even in chal-
lenging aortic anatomies.
The duration of procedures, intraoperative contrast use and
radiation exposure time were similar in both groups, indirectly
demonstrating an absence of additional intraoperative difﬁculties.
The particular characteristics of this device seem to make it
appropriate for the treatment of highly angulated and short necks,
especially in patients at high surgical risk.
The clinical signiﬁcance of our study was to demonstrate the
effectiveness of the Endurant stent-graft even in the case of difﬁcult
anatomies, as well as its postoperative safeness in the case of off-
label indications in patients otherwise considered unﬁt for
surgery, although our results are related to only 1-month follow up.
It is important to note that this kind of procedure should be per-
formed by skilled operators in high volume centres.
Mid- and long-term data are needed to verify the durability of
the procedure, but early results are promising and challenge
current opinion concerning the negative inﬂuence of challenging
neck anatomy on EVAR.
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